Irvine Newswire

Irvine Newswire

Comprehensive Real-Time News Feed for Irvine, CA.

Results 1 - 20 of 60 for "u:biospace.com" in Irvine, CA

  1. Nitto Avecia Announces Multiple Oligonucleotide ExpansionsRead the original story

    Sunday Nov 13 | BioSpace

    Nitto Avecia Inc. today released its progress in expanding the company's analytical development and oligonucleotide manufacturing capacities. The announcement signals the continuation of Avecia's robust growth strategy to significantly increase its oligonucleotide drug substance manufacturing capacity in Milford, MA along with the addition of drug product capacity in Irvine, CA and analytical development capabilities in Irvine, CA and Marlboro, MA.

    Comment?

  2. MDxHealth, Inc.'s AssureMDx Multi-Center Validation Study Published InRead the original story

    Wednesday Nov 9 | BioSpace

    Prof. Dr. Ellen Zwarthoff, Erasmus MC Cancer Institute stated: "This pan-European multi-center validation study confirms the very high negative predictive value of the AssureMDx test.

    Comment?

  3. FDA Clearance For Vaporflex And Legato Electrosurgical ProbesRead the original story

    Tuesday Nov 8 | BioSpace

    IRVINE, Calif. & KARLSRUHE, Germany-- --joimaxA , the global acting German developer and marketer of technologies and training methods for endoscopic minimally-invasive spinal surgery, today announced 510 clearance from the U.S. Food and Drug Administration to market its VaporflexA and LegatoA electrosurgical probes with radiowave technology for open and endoscopic spine surgery.

    Comment?

  4. Royal Philips Electronics N.V. And Masimo Sign Multi-Year Business...Read the original story

    Sunday Nov 6 | BioSpace

    Multi-year business partnership combines Masimo's expertise in non-invasive sensor and signal processing technologies and Philips' expertise in integrated patient monitoring and therapy solutions Business partnership involves technology integration and marketing and sales cooperation in North America and certain markets in Asia and Europe Agreement ends all pending lawsuits between the two companies and, in addition to marketing and integration commitments, includes a cash payment of USD 300 million by Philips to Masimo AMSTERDAM & IRVINE, Calif.-- --Royal Philips and Masimo Corporation today announced a wide-ranging, multi-year business partnership involving both companies' innovations in patient monitoring and therapy solutions.

    Comment?

  5. MRI Interventions Announces 2016 Third Quarter And Nine Month ResultsRead the original story

    Thursday Nov 3 | BioSpace

    IRVINE, Calif., Nov. 04, 2016 -- MRI Interventions, Inc. today announced financial results for the quarter and nine months ended September 30, 2016. Quarter Ended September 30, 2016 - Highlights * Achieved a record quarterly number of procedures with 128 patients benefitting from the Company's ClearPoint technology, a 32% increase in procedures over the same period in 2015; * Revenues were $1.6 million for the three months ended September 30, 2016, and $1.2 million for the same period in 2015, an increase of 30%.

    Comment?

  6. Med Alliance Release: Initial Patients Enrolled In First-in-Man...Read the original story

    Nov 1, 2016 | BioSpace

    Patients were enrolled at the Universitaets-Herzzentrum, Bad Krozingen, Germany, and the Franziskus Krankenhaus, Berlin, Germany. SELUTION contains micro-reservoirs made out of biodegradable polymer intermixed with sirolimus.

    Comment?

  7. MDxHealth, Inc. Announces Unique CPT Code Awarded For ConfirmMDx From American Medical AssociationRead the original story

    Oct 30, 2016 | BioSpace

    Current Procedural Terminology code will facilitate reimbursement IRVINE, CA, and HERSTAL, BELGIUM - October 31, 2016 - MDxHealth SA , today announced that its ConfirmMDxA for Prostate Cancer test has been granted a Category I MAAA Current Procedural Terminology code by the American Medical Association . "Obtaining Category I CPT code for ConfirmMDx is an important reimbursement milestone that can only be achieved once there is sufficient evidence demonstrating the test improves patient outcomes, has the support of the specialty medical associations, inclusion in medical guidelines and widespread physician adoption," stated Dr. Jan Groen, CEO of MDxHealth.

    Comment?

  8. OCTANe Announces New Operating GroupRead the original story

    Oct 30, 2016 | BioSpace

    OCTANe , Orange County's life sciences and technology accelerator organization, today announced at its annual Medical Device & Investor Forum the formation of a new operating group, OCTANe Growth Services. The new group will provide OCTANe's members, partners, investors, entrepreneurs and LaunchPad SBDC alumni with more access to resources, intelligence, capital and better deal flow.

    Comment?

  9. InoLife Technologies, Inc. Obtains A $500,000 FinancingRead the original story

    Oct 26, 2016 | BioSpace

    Inolife Technologies Inc. , the emerging leader of needle free injection devices, announced today that it has obtained a $500,000 financing from the F. Bertucci Family Trust. According to the terms of the agreement, Inolife has issued a convertible debenture in the amount of $500,000 U.S. and said debenture converts at any time during the term at a price of $1.00 per share.

    Comment?

  10. FDA Reclassifies Johnson & Johnson Acclarent's Aera Eustachian Tube Balloon to a Class II DeviceRead the original story

    Oct 24, 2016 | BioSpace

    The FDA today said it reclassified Johnson & Johnson subsidiary Acclarent's Aera Eustachian tube balloon to a Class II device. The Irvine, Calif.-based company's Aera system consists of a balloon catheter designed to be inserted through the patient's nose into the Eustachian tube.

    Comment?

  11. Agendia BV Appoints Three Leading Cancer Physicians To Its Medical Advisory BoardRead the original story

    Oct 16, 2016 | BioSpace

    Irvine, CA, USA and Amsterdam, the Netherlands, October 17, 2016 / B3C newswire / -- Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today the appointment of three new members to its Medical Advisory Board. Prof.

    Comment?

  12. Nitto Denko Avecia Inc. Acquires The Businesses Of Irvine...Read the original story

    Oct 11, 2016 | BioSpace

    Nitto Denko Avecia Inc. , today announced it has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals , both located in Irvine, CA. Irvine is a leading analytical development services provider and Avrio is a premier cGMP parenteral contract manufacturing organization.

    Comment?

  13. Nitto Denko Avecia Inc. Acquires The Businesses Of Irvine...Read the original story

    Oct 11, 2016 | BioSpace

    Irvine is a leading analytical development services provider and Avrio is a premier cGMP parenteral contract manufacturing organization. Avecia will consolidate both businesses into the newly established company, Nitto Avecia Pharma Services.

    Comment?

  14. Harbor MedTech Forms Advisory Board Of Leading Wound Care SpecialistsRead the original story

    Oct 6, 2016 | BioSpace

    Harbor MedTech, Inc., a commercial-stage regenerative medicine company delivering innovative biologic wound-healing products, today announced that it has established a medical advisory board comprised of some of the country's foremost chronic wound care experts. The group will meet at the Symposium on Advanced Wound Care in Las Vegas, Oct. 7-9, 2016.

    Comment?

  15. Top 5 Best U.S. Cities for Life Science Research Associate JobsRead the original story

    Oct 5, 2016 | BioSpace

    October 6, 2016 By Mark Terry , BioSpace.com Breaking News Staff There are many ways of deciding which city or region is best for you - nearby family, weather, traffic, housing prices and, of course, jobs. Life science grads looking for research associate jobs in the U.S. may take into account all of those or only some.

    Comment?

  16. MDxHealth, Inc. Announces Agreement With For Distribution Of SelectMDx In Central/South AmericaRead the original story

    Oct 3, 2016 | BioSpace

    IRVINE, CA, and HERSTAL, BELGIUM - October 4, 2016 - MDxHealth SA a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of urologic cancers, today announced that it has signed a distribution agreement for their SelectMDx for Prostate Cancer assay in select countries in Central and South America with SouthGenetics Inc. Under the terms of the agreement SouthGenetics, a biotechnology distribution company based in Montevideo, Uruguay, will have the rights to distribute SelectMDx assay within the following countries: Argentina, Bolivia, Chili, Columbia, Ecuador, Mexico, Peru, Dominican Republic, Panama, Paraguay, Uruguay, and Venezuela.

    Comment?

  17. Axonics Modulation Tech Granted New U.S. Patent Related To Its...Read the original story

    Sep 25, 2016 | BioSpace

    Axonics Modulation Technologies, Inc. , developer of the first rechargeable implantable Sacral Neuromodulation System for the treatment of urinary and fecal dysfunction, announced today that the United States Patent and Trademark Office has granted Axonics a new U.S. patent relating to its implantable neuromodulation technology for the treatment of urinary and fecal dysfunction. "With this new U.S. patent, we now have sixty-one issued and eighty-five pending patent applications in our portfolio in various jurisdictions around the world."

    Comment?

  18. MDxHealth, Inc. Announces Upgraded Revenue ForecastRead the original story

    Sep 21, 2016 | BioSpace

    Company expects to significantly exceed upper range of previous guidance Accelerated Growth attributed to increased payor coverage IRVINE, CA, and HERSTAL, BELGIUM - September 22, 2016 - MDxHealth SA announced today that its preliminary unaudited revenues are expected to significantly exceed the upper end of full year guidance. Revenue for the year is expected to exhibit growth of more than 60% over the previous year, compared with prior guidance predicting growth of 30-50%.

    Comment?

  19. MRI Interventions To Present At Upcoming Investor ConferencesRead the original story

    Sep 14, 2016 | BioSpace

    IRVINE, Calif., Sept. 15, 2016 -- MRI Interventions, Inc. , the leader in Neuro Navigation utilizing intraoperative MRI guidance, today announced that Frank Grillo, President and CEO, will present at two upcoming investor conferences: The 2016 Aegis Growth Conference being held at The Encore at Wynn Las Vegas in Las Vegas, Nevada, September 20-22; and Mr. Grillo's presentation may be accessed on the Company's website at www.mriinterventions.com by selecting the "Investors" menu, and then selecting the "Investor Presentations" page.

    Comment?

  20. OCTANe Announces Agenda For 11th Annual Medical Device & Investor ForumRead the original story

    Sep 13, 2016 | BioSpace

    OCTANe , Orange County's life sciences and technology accelerator organization, today announced the final agenda for its 11th Annual Medical Device & Investor Forum on October 27-28, 2016 in Irvine, Calif. The lineup includes executives and experts from among the leading medical technology companies in the area, including Edwards Lifesciences, Carl Zeiss Meditec, Allergan and Medtronic.

    Comment?

Irvine Job Listings
View or post Irvine job listings on Topix.
Irvine Real Estate
News, listings, and foreclosures in Irvine from Topix.
Irvine Mortgages
Find mortgage rates in Irvine on Topix.